Titre : Relations interprofessionnelles

Relations interprofessionnelles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Relations interprofessionnelles : Questions médicales les plus fréquentes", "headline": "Relations interprofessionnelles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Relations interprofessionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relations interpersonnelles", "url": "https://questionsmedicales.fr/mesh/D007398", "about": { "@type": "MedicalCondition", "name": "Relations interpersonnelles", "code": { "@type": "MedicalCode", "code": "D007398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Relations médecin-infirmier", "alternateName": "Physician-Nurse Relations", "url": "https://questionsmedicales.fr/mesh/D019555", "about": { "@type": "MedicalCondition", "name": "Relations médecin-infirmier", "code": { "@type": "MedicalCode", "code": "D019555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401.205.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles", "alternateName": "Interprofessional Relations", "code": { "@type": "MedicalCode", "code": "D007400", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fatemeh Keshmiri", "url": "https://questionsmedicales.fr/author/Fatemeh%20Keshmiri", "affiliation": { "@type": "Organization", "name": "Associate Professor, Medical Education Department, Education Development Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran." } }, { "@type": "Person", "name": "Erin Abu-Rish Blakeney", "url": "https://questionsmedicales.fr/author/Erin%20Abu-Rish%20Blakeney", "affiliation": { "@type": "Organization", "name": "School of Nursing, University of Washington , Seattle , WA , USA." } }, { "@type": "Person", "name": "Azam Hosseinpour", "url": "https://questionsmedicales.fr/author/Azam%20Hosseinpour", "affiliation": { "@type": "Organization", "name": "Instructor, Department of Operating Room, School of Allied Medical Sciences, Qom University of Medical Sciences, Qom, Iran." } }, { "@type": "Person", "name": "Katja Krug", "url": "https://questionsmedicales.fr/author/Katja%20Krug", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de." } }, { "@type": "Person", "name": "Michel Wensing", "url": "https://questionsmedicales.fr/author/Michel%20Wensing", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Challenges and complications in juvenile localized scleroderma: A practical approach.", "datePublished": "2024-09-17", "url": "https://questionsmedicales.fr/article/39294014", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.berh.2024.101987" } }, { "@type": "ScholarlyArticle", "name": "Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.", "datePublished": "2024-05-24", "url": "https://questionsmedicales.fr/article/38798225", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2174/0115734056299155240516102231" } }, { "@type": "ScholarlyArticle", "name": "Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging.", "datePublished": "2024-01-19", "url": "https://questionsmedicales.fr/article/38415131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21037/qims-23-980" } }, { "@type": "ScholarlyArticle", "name": "[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma].", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36520171", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00393-022-01296-0" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma and scleroderma-like syndromes.", "datePublished": "2024-06-03", "url": "https://questionsmedicales.fr/article/38887288", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2024.1351675" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Relations interpersonnelles", "item": "https://questionsmedicales.fr/mesh/D007398" }, { "@type": "ListItem", "position": 4, "name": "Relations interprofessionnelles", "item": "https://questionsmedicales.fr/mesh/D007400" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Relations interprofessionnelles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Relations interprofessionnelles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Relations interprofessionnelles", "description": "Comment évaluer la communication interprofessionnelle ?\nQuels indicateurs mesurent la collaboration interprofessionnelle ?\nQuels outils facilitent le diagnostic interprofessionnel ?\nComment identifier les barrières à la collaboration ?\nQuel rôle joue la culture organisationnelle dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Relations interprofessionnelles", "description": "Quels symptômes indiquent une mauvaise communication ?\nComment reconnaître un manque de collaboration ?\nQuels symptômes affectent la dynamique d'équipe ?\nQuels signes montrent une bonne collaboration ?\nComment les symptômes de stress impactent-ils les relations ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Relations interprofessionnelles", "description": "Comment prévenir les conflits interprofessionnels ?\nQuelles stratégies améliorent la prévention des erreurs ?\nComment sensibiliser à l'importance de la collaboration ?\nQuels outils aident à la prévention des erreurs médicales ?\nComment la prévention impacte-t-elle les soins ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Relations interprofessionnelles", "description": "Comment améliorer les traitements par la collaboration ?\nQuels traitements favorisent la communication ?\nComment évaluer l'efficacité des traitements interprofessionnels ?\nQuels traitements sont adaptés aux équipes interprofessionnelles ?\nComment les traitements peuvent-ils être personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Relations interprofessionnelles", "description": "Quelles complications résultent d'une mauvaise communication ?\nComment les conflits affectent-ils les résultats des soins ?\nQuelles complications peuvent survenir en cas de mauvaise collaboration ?\nComment évaluer l'impact des complications sur les soins ?\nQuelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Relations interprofessionnelles", "description": "Quels facteurs augmentent le risque de conflits ?\nComment le stress influence-t-il les relations interprofessionnelles ?\nQuels facteurs de risque sont liés à la collaboration ?\nComment les différences de statut affectent-elles les relations ?\nQuels facteurs environnementaux influencent la collaboration ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la communication interprofessionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des outils d'évaluation comme des questionnaires et des entretiens." } }, { "@type": "Question", "name": "Quels indicateurs mesurent la collaboration interprofessionnelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent la satisfaction des patients et l'efficacité des soins." } }, { "@type": "Question", "name": "Quels outils facilitent le diagnostic interprofessionnel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des plateformes de partage d'informations et des réunions d'équipe." } }, { "@type": "Question", "name": "Comment identifier les barrières à la collaboration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes et des discussions en groupe pour recueillir des retours d'expérience." } }, { "@type": "Question", "name": "Quel rôle joue la culture organisationnelle dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une culture ouverte favorise la communication et la collaboration entre les professionnels." } }, { "@type": "Question", "name": "Quels symptômes indiquent une mauvaise communication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs médicales fréquentes et des plaintes des patients peuvent en être des signes." } }, { "@type": "Question", "name": "Comment reconnaître un manque de collaboration ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits fréquents et un manque de coordination dans les soins sont des indicateurs." } }, { "@type": "Question", "name": "Quels symptômes affectent la dynamique d'équipe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la frustration et le turnover élevé peuvent affecter la dynamique d'équipe." } }, { "@type": "Question", "name": "Quels signes montrent une bonne collaboration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une communication fluide et des résultats positifs pour les patients sont des signes clés." } }, { "@type": "Question", "name": "Comment les symptômes de stress impactent-ils les relations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut mener à des conflits et à une communication inefficace entre les professionnels." } }, { "@type": "Question", "name": "Comment prévenir les conflits interprofessionnels ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par des formations régulières sur la communication et la gestion des conflits." } }, { "@type": "Question", "name": "Quelles stratégies améliorent la prévention des erreurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles clairs et des revues de cas régulières." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance de la collaboration ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des séminaires et des ateliers sur les bénéfices de la collaboration interprofessionnelle." } }, { "@type": "Question", "name": "Quels outils aident à la prévention des erreurs médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les check-lists et les systèmes de double vérification sont des outils efficaces." } }, { "@type": "Question", "name": "Comment la prévention impacte-t-elle les soins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne prévention réduit les erreurs et améliore la satisfaction des patients." } }, { "@type": "Question", "name": "Comment améliorer les traitements par la collaboration ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "En intégrant des équipes multidisciplinaires pour une approche globale des soins." } }, { "@type": "Question", "name": "Quels traitements favorisent la communication ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des formations en communication et des ateliers de team-building sont bénéfiques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements interprofessionnels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Par des études de cas et des analyses de résultats cliniques post-traitement." } }, { "@type": "Question", "name": "Quels traitements sont adaptés aux équipes interprofessionnelles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements complexes comme la gestion de la douleur nécessitent une approche collaborative." } }, { "@type": "Question", "name": "Comment les traitements peuvent-ils être personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En tenant compte des compétences et des expertises de chaque professionnel de santé." } }, { "@type": "Question", "name": "Quelles complications résultent d'une mauvaise communication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs de traitement et des retards dans les soins peuvent survenir." } }, { "@type": "Question", "name": "Comment les conflits affectent-ils les résultats des soins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits peuvent mener à des soins fragmentés et à une insatisfaction des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de mauvaise collaboration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications médicales et des réadmissions fréquentes peuvent en résulter." } }, { "@type": "Question", "name": "Comment évaluer l'impact des complications sur les soins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses de données sur les résultats cliniques et la satisfaction des patients." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise dynamique peut entraîner un turnover élevé et une baisse de la qualité des soins." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de conflits ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des différences culturelles et des styles de communication variés peuvent augmenter les conflits." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les relations interprofessionnelles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut réduire la communication et augmenter les tensions entre les professionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque sont liés à la collaboration ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un manque de formation et des horaires de travail chargés peuvent nuire à la collaboration." } }, { "@type": "Question", "name": "Comment les différences de statut affectent-elles les relations ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les différences de statut peuvent créer des déséquilibres et des tensions dans l'équipe." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent la collaboration ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement de travail positif et des ressources adéquates favorisent la collaboration." } } ] } ] }

Sources (10000 au total)

Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.

Although clinical assessment has historically been the primary method used for pediatric localized sclerosis (LS) diagnosis and staging, highfrequency ultrasonography (HFUS) is being investigated as a... This study aimed to assess, compare dermal and subcutaneous tissue characteristics and enhance enhance lesion staging in pediatric LS patients using HFUS.... Twenty two LS patients were cross-sectionally evaluated with B-mode ultrasonography. Lesions were clinically staged, and dermal and subcutaneous tissue characteristics were compared with healthy tissu... Among 55 lesions, 27 were active/new (49.1%), and 28 were atrophic/old (50.9%). Active lesions typically had increased dermal thickness in 66.6% of cases, while atrophic lesions often showed decreased... Ultrasonography offers an objective LS lesion evaluation, especially in pediatrics....

Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging.

Localized scleroderma (LoS) is an autoimmune disease in which craniofacial lesions can cause severe facial deformities with brain involvement. Objective evaluation of craniofacial LoS is challenging. ... This cross-sectional study included patients with craniofacial LoS from September 2021 to August 2022 in Peking Union Medical College Hospital. Patients who were clinically assessed in a stable phase ... A total of 28 patients were included (13 female; mean age, 18 years). MRI showed a good correlation and agreement with ultrasound (r=0.916, P<0.001). In different facial subunits, a significant negati... MRI can reliably quantify damage in craniofacial LoS, and may serve as a useful and objective tool for overall craniofacial LoS evaluation....

[Validation of the total morbidity score and investigation of the efficacy of methotrexate in localized scleroderma].

Localized scleroderma is an autoimmune disease belonging to the group of collagenoses, which can manifest cutaneously and extracutaneously. The extracutaneous manifestations may have significant morbi... In the retrospective monocentric study at the Hamburg Center for Pediatric and Adolescent Rheumatology, the TMS was applied to patients from 2004-2019 suffering from localized scleroderma who had at l... Due to a lack of control presentations, data from 51 of the 95 patients with a confirmed diagnosis could be included in the retrospective evaluation. The treatment of these patients was considered ove... The evaluation showed that the TMS total score is mainly fed by the extracutaneous manifestations, demonstrating the inaccuracy of previous scores. Another advantage of the TMS is that different score...

Case Report: Exacerbation after fat grafting in patients with active localized scleroderma.

The application of autologous fat transplantation in facial lesions of patients with localized scleroderma (LoS) has been reported in recent years.... The authors report a case of worsening of active localized scleroderma after autologous fat transplantation.... A man presented with neck and facial skin atrophy and pigmentation with a history of LoS. Appearing 1.5 years ago, the lesion had progressively grown in size and shape. Consent was obtained after the ... Skin dyspigmentation and atrophy progressively deteriorated 1 month into therapy, with slightly increased erythema and enlargement of the lesion. Six months after the therapy, the localized scleroderm... There are different factors, such as that systemic medications could affect the treatment of localized scleroderma by autologous fat transplantation. Meanwhile, considering the limitation of the 6-mon... More clinical research is needed to determine the time interval between disease inactivity and the application of any surgical procedures to avoid reactivation....